From De Novo to Xeno: Advancing Macromolecule Design beyond Proteins
ACS Synthetic Biology · 16.08.2024 · 13 (8) · 2271-2275
DOI: 10.1021/acssynbio.4c00179 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 16.08.2024. Verfasst von Tyler Stukenbroeker. Beteiligte Einrichtung: Telescope Scientific Consulting, Richmond, Virginia 23221, United States. Hauptthemen laut MEDLINE: Proteins, Macromolecular Substances, Protein Engineering. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Protein synthesis methods have been adapted to incorporate an ever-growing level of non-natural components. Meanwhile, design of de novo protein structure and function has rapidly emerged as a viable capability. Yet, these two exciting trends have yet to intersect in a meaningful way. The ability to perform de novo design with non-proteinogenic components requires that synthesis and computation align on common targets and applications. This perspective examines the state of the art in these areas and identifies specific, consequential applications to advance the field toward generalized macromolecule design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Telescope Scientific Consulting, Richmond, Virginia 23221, United States.
ORCID-Profile: Tyler Stukenbroeker
Zitieren
APA
Stukenbroeker, T. (2024). From De Novo to Xeno: Advancing Macromolecule Design beyond Proteins. ACS Synthetic Biology, 13(8), 2271-2275. https://doi.org/10.1021/acssynbio.4c00179
Vancouver
Stukenbroeker T. From De Novo to Xeno: Advancing Macromolecule Design beyond Proteins. ACS Synthetic Biology. 2024;13(8):2271-2275. doi:10.1021/acssynbio.4c00179
BibTeX
@article{Stukenbroeker2024,
author = {Stukenbroeker, Tyler},
title = {From De Novo to Xeno: Advancing Macromolecule Design beyond Proteins},
journal = {ACS Synthetic Biology},
year = {2024},
volume = {13},
number = {8},
pages = {2271--2275},
doi = {10.1021/acssynbio.4c00179}
}
EUVIMED